Department of Urology, University of Virginia, P.O. Box 800422, Charlottesville, VA, 22908, USA.
Department of Urology, MedStar Health Georgetown University Hospital, Washington, DC, USA.
World J Urol. 2020 Sep;38(9):2247-2252. doi: 10.1007/s00345-019-03005-0. Epub 2019 Nov 15.
We sought to determine the effect of active versus passive voiding trials on time to hospital discharge and rates of urinary tract infection (UTI) and urinary retention (UR).
We performed a prospective, randomized trial comparing active (AVT) versus passive (PVT) void trials of inpatients requiring urethral catheter removal. Of 329 eligible patients, 274 were randomized to AVT (bladder filled with saline before catheter removal) or PVT (spontaneous bladder filling after catheter removal). Primary outcome was time to hospital discharge. Secondary outcomes were UTI (NSQIP criteria) and UR (requiring repeat catheterization) within 2 weeks of void trial.
The median time to void was 18 (5-115) versus 236 (136-360) min in the AVT and PVT groups, respectively (p < 0.0001). However, no difference was seen in comparison of the median time to hospital discharge between AVT [28.4 (13.6-69.3) h] and PVT [30.0 (10.4-75.6) h] cohorts, respectively (p = 0.93). Six (4.8%) and 13 (12.9%) patients developed UTI in the AVT and PVT groups, respectively (p = 0.03). Eleven (8.8%) and 12 (11.9%) patients developed UR in the AVT and PVT groups, respectively (p = 0.36).
Our study comparing AVT versus PVT demonstrated no difference in time to discharge despite a 3.6 h reduction in time to void associated with AVT. AVT was associated with a 63% reduction in UTI, with no difference seen in UR rates across cohorts. Given the reduction in UTI and technical advantages, our data suggest that AVT should be considered as a recommended technique for void trial protocol.
NCT02886143 (clinicaltrials.gov).
本研究旨在比较主动排尿试验(AVT)与被动排尿试验(PVT)对患者住院时间、尿路感染(UTI)和尿潴留(UR)发生率的影响。
我们进行了一项前瞻性、随机试验,比较了需要拔除导尿管的住院患者的主动(AVT)和被动(PVT)排尿试验。在 329 名符合条件的患者中,274 名被随机分配至 AVT 组(拔除导尿管前膀胱充盈生理盐水)或 PVT 组(拔除导尿管后自然膀胱充盈)。主要结局为住院时间。次要结局为在排尿试验后 2 周内发生的 UTI(NSQIP 标准)和 UR(需要再次导尿)。
AVT 组和 PVT 组的中位排尿时间分别为 18(5-115)分钟和 236(136-360)分钟(p<0.0001)。然而,AVT 组[28.4(13.6-69.3)小时]和 PVT 组[30.0(10.4-75.6)小时]的中位住院时间无显著差异(p=0.93)。AVT 组和 PVT 组分别有 6(4.8%)和 13(12.9%)例患者发生 UTI(p=0.03)。AVT 组和 PVT 组分别有 11(8.8%)和 12(11.9%)例患者发生 UR(p=0.36)。
本研究比较了 AVT 与 PVT,结果显示,尽管 AVT 组的排尿时间缩短了 3.6 小时,但两组患者的出院时间无显著差异。AVT 组 UTI 发生率降低了 63%,两组的 UR 发生率无显著差异。鉴于 UTI 发生率降低和技术优势,我们的数据表明,AVT 应作为推荐的排尿试验方案。
NCT02886143(clinicaltrials.gov)。